Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

Stefano Sacchi, Raffaella Marcheselli, Alessia Bari, Gabriele Buda, Anna Lia Molinari, Luca Baldini, Daniele Vallisa, Marina Cesaretti, Pellegrino Musto, Sonia Ronconi, Giorgina Specchia, Franco Silvestris, Luciano Guardigni, Angela Ferrari, Annalisa Chiapella, Angelo Michele Carella, Armando Santoro, Francesco Di Raimondo, Luigi Marcheselli, Sacchi Samantha Pozzi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e196-9
JournalHaematologica
Volume101
Issue number5
DOIs
Publication statusPublished - May 2016

Keywords

  • Letter

Cite this